Biolinq today shared new clinical findings supporting the use of its autonomous, needle-free continuous glucose monitor (CGM). San Diego-based Biolinq develops the Shine sensor, which integrates glucose, activity and sleep information into a single device with autonomous operation. The first-of-its-kind system utilizes a patch on the forearm to provide real-time glucose feedback through a primary … Continue reading Biolinq data backs autonomous, needle-free CGM